Alterity Therapeutics Limited Stock
Stocks
ATH
AU0000043945
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5600 AUD | -2.61% |
|
-5.08% | +40.00% |
| Market Cap | 85.18M 74.81M 69.57M 63.84M 120M 8.2B 122M 826M 323M 4.03B 320M 313M 13.94B | P/E 2026 * |
-0.33x | P/E 2027 * | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 39.99M 35.12M 32.66M 29.97M 56.32M 3.85B 57.19M 388M 152M 1.89B 150M 147M 6.55B | EV / Sales 2026 * |
15.6x | EV / Sales 2027 * | 36.9x |
| Free-Float |
91.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alterity Therapeutics Limited
| 1 day | -2.61% | ||
| 1 week | -5.08% | ||
| Current month | -2.61% | ||
| 1 month | -2.61% | ||
| 3 months | +12.00% | ||
| 6 months | +40.00% | ||
| Current year | +40.00% |
| 1 week | 0.54 |  | 0.59 |
| 1 month | 0.54 | | 0.78 |
| Current year | 0.35 | | 0.78 |
| 1 year | 0.35 | | 0.85 |
| 3 years | 0.1 | | 0.95 |
| 5 years | 0.1 | | 1.9 |
| 10 years | 0.1 | | 20.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 2021-01-06 |
Abby Niven
DFI | Director of Finance/CFO | - | 2024-09-29 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 2005-07-28 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 2011-08-07 |
David Stamler
BRD | Director/Board Member | 65 | 2025-11-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/15/26 | Free | Director | 1,000,000 | 0.0092% | ||
| 6/15/26 | Free | Director | 1,000,000 | 0.0092% | ||
| 6/15/26 | Free | Chairman | 2,000,000 | 0.0184% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.61% | -5.08% | -25.33% | +86.67% | 87.19M | |
| +1.07% | -3.49% | -3.25% | +12.87% | 46.35B | |
| +0.25% | +1.65% | +408.41% | +629.49% | 40.13B | |
| -0.27% | +4.45% | +9.93% | +66.92% | 36.33B | |
| +0.35% | +0.87% | +3.60% | -8.81% | 34.6B | |
| +3.14% | +1.02% | +3.37% | +38.15% | 26.77B | |
| -0.73% | +11.84% | +31.97% | +143.53% | 16.91B | |
| +0.47% | -2.74% | - | - | 16.66B | |
| +0.42% | -5.52% | +0.76% | +8.50% | 13.05B | |
| -2.68% | -2.49% | -15.00% | -31.68% | 13.05B | |
| Average | -0.06% | +0.64% | +46.05% | +105.07% | 24.39B | |
| Weighted average by Cap. | +0.46% | +1.10% | +75.53% | +137.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57M 2.26M 2.1M 1.93M 3.62M 247M 3.67M 24.91M 9.73M 122M 9.64M 9.43M 420M | 1.2M 1.05M 980K 900K 1.69M 116M 1.72M 11.64M 4.55M 56.83M 4.51M 4.41M 196M |
| Net income | -14.64M -12.86M -11.96M -10.98M -20.62M -1.41B -20.94M -142M -55.49M -693M -54.97M -53.79M -2.4B | -29.66M -26.05M -24.23M -22.23M -41.77M -2.86B -42.41M -288M -112M -1.4B -111M -109M -4.86B |
| Net Debt | -45.19M -39.69M -36.91M -33.87M -63.64M -4.35B -64.62M -438M -171M -2.14B -170M -166M -7.4B | -40.88M -35.91M -33.39M -30.64M -57.57M -3.94B -58.46M -397M -155M -1.94B -153M -150M -6.69B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | A$0.5600 | -2.61% | 258,611 |
| 26-07-23 | A$0.5750 | +1.77% | 61,936 |
| 26-07-22 | A$0.5650 | +2.73% | 76,784 |
| 26-07-21 | A$0.5500 | 0.00% | 28,306 |
| 26-07-20 | A$0.5500 | -6.78% | 688,512 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
Select your edition
All financial news and data tailored to specific country editions
